Cargando…
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
BACKGROUND: The WHO Essential Medicines List (EML) identifies priority medicines that are most important to public health. Over time, the EML has included an increasing number of cancer medicines. We aimed to investigate whether the cancer medicines in the EML are aligned with the priority medicines...
Autores principales: | Fundytus, Adam, Sengar, Manju, Lombe, Dorothy, Hopman, Wilma, Jalink, Matthew, Gyawali, Bishal, Trapani, Dario, Roitberg, Felipe, De Vries, Elisabeth G E, Moja, Lorenzo, Ilbawi, André, Sullivan, Richard, Booth, Christopher M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476341/ https://www.ncbi.nlm.nih.gov/pubmed/34560006 http://dx.doi.org/10.1016/S1470-2045(21)00463-0 |
Ejemplares similares
-
Cancer Medicines: What Is Essential and Affordable in India?
por: Sengar, Manju, et al.
Publicado: (2022) -
Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey
por: Denburg, Avram E., et al.
Publicado: (2022) -
Delivery of Global Cancer Care: An International Study of Medical
Oncology Workload
por: Fundytus, Adam, et al.
Publicado: (2017) -
Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity
por: Sengar, Manju, et al.
Publicado: (2023) -
Cancer care workforce in Africa: perspectives from a global survey
por: Vanderpuye, Verna, et al.
Publicado: (2019)